+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Eurobio Scientific SA (ALERS) - Product Pipeline Analysis, 2020 Update

  • ID: 5240136
  • Company Profile
  • January 2021
  • 45 pages
  • GlobalData

FEATURED COMPANIES

  • Biosynex SA
  • ERYTECH Pharma SA
  • Innate Pharma SA
  • IntegraGen SA
  • Ipsen SA
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves a range of therapeutic areas including infectious diseases, Alzheimer's disease and cancer. The company commercializes in vitro diagnostic kits and instruments through its affiliate Ingen. It has presence in France and the US. Eurobio is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Eurobio Scientific SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biosynex SA
  • ERYTECH Pharma SA
  • Innate Pharma SA
  • IntegraGen SA
  • Ipsen SA
Eurobio Scientific SA Company Overview
  • Eurobio Scientific SA Company Snapshot
  • Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
  • Eurobio Scientific SA - Pipeline Analysis Overview
  • Eurobio Scientific SA - Key Facts
  • Eurobio Scientific SA - Major Products and Services
  • Eurobio Scientific SA Pipeline Products by Development Stage
  • Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA Pipeline Products Overview
  • CO-3S Companion Diagnostic Assay
  • CO-3S Companion Diagnostic Assay Product Overview
  • Companion Diagnostic Test - Breast Cancer
  • Companion Diagnostic Test - Breast Cancer Product Overview
  • DHT Dx15
  • DHT Dx15 Product Overview
  • DHT Dx15 Clinical Trial
  • DIAG-3S Diagnostic Assay
  • DIAG-3S Diagnostic Assay Product Overview
  • Disease Evolution Predictive Test - AIDS
  • Disease Evolution Predictive Test - AIDS Product Overview
  • EHT Dx 11
  • EHT Dx 11 Product Overview
  • EHT Dx 12
  • EHT Dx 12 Product Overview
  • EHT Dx13
  • EHT Dx13 Product Overview
  • EHT Dx14
  • EHT Dx14 Product Overview
  • EHT Dx23
  • EHT Dx23 Product Overview
  • T-COR 8 - Dengue Fever
  • T-COR 8 - Dengue Fever Product Overview
  • T-COR 8 - Meningitis
  • T-COR 8 - Meningitis Product Overview
  • Therapeutic Drug Monitoring Test - Resistant Cancer
  • Therapeutic Drug Monitoring Test - Resistant Cancer Product Overview
  • VAC-3S Companion Diagnostic Test
  • VAC-3S Companion Diagnostic Test Product Overview
Eurobio Scientific SA - Key Competitors

Eurobio Scientific SA - Key Employees

Eurobio Scientific SA - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Eurobio Scientific SA, Recent Developments
  • Oct 15, 2019: Eurobio Scientific: Strong earnings growth for the first half of 2019
  • Jul 23, 2019: Eurobio Scientific's activity for the first half of 2019: Strong growth of sales
  • Jan 29, 2019: Eurobio Scientific reaches the €50m sales mark in 2018
  • Jul 23, 2018: Eurobio Scientific: 2018 mid-year activity report
  • Jun 30, 2018: Eurobio Scientific announce 2018 mid year results
  • Feb 15, 2018: Diaxonhit: Exclusive distribution of the VERIGENE molecular biology platform
  • Mar 24, 2016: Diaxonhit: Further progress of commercial activity Initial sales of proprietary products
  • Jan 26, 2016: Diaxonhit: 2015 Consolidated Income: €29.5 M
  • Sep 24, 2015: Diaxonhit: 2015 mid-year results
  • Jul 30, 2015: Encouraging results of the first clinical study of the VAC-3S vaccine against HIV, for which DIAXONHIT develops Companion Diagnostic Assay CO-3S
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
  • Eurobio Scientific SA Pipeline Products by Equipment Type
  • Eurobio Scientific SA Pipeline Products by Indication
  • Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
  • Eurobio Scientific SA, Key Facts
  • Eurobio Scientific SA, Major Products and Services
  • Eurobio Scientific SA Number of Pipeline Products by Development Stage
  • Eurobio Scientific SA Pipeline Products Summary by Development Stage
  • Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
  • Eurobio Scientific SA Ongoing Clinical Trials Summary
  • CO-3S Companion Diagnostic Assay - Product Status
  • CO-3S Companion Diagnostic Assay - Product Description
  • Companion Diagnostic Test - Breast Cancer - Product Status
  • Companion Diagnostic Test - Breast Cancer - Product Description
  • DHT Dx15 - Product Status
  • DHT Dx15 - Product Description
  • DHT Dx15 - Clinical Validation of the Diagnostic Performance of a Molecular Signature to Determine the Malignant or Benign Profile of a Thyroid Nodule with Indeterminate Cytological Analysis
  • DIAG-3S Diagnostic Assay - Product Status
  • DIAG-3S Diagnostic Assay - Product Description
  • Disease Evolution Predictive Test - AIDS - Product Status
  • Disease Evolution Predictive Test - AIDS - Product Description
  • EHT Dx 11 - Product Status
  • EHT Dx 11 - Product Description
  • EHT Dx 12 - Product Status
  • EHT Dx 12 - Product Description
  • EHT Dx13 - Product Status
  • EHT Dx13 - Product Description
  • EHT Dx14 - Product Status
  • EHT Dx14 - Product Description
  • EHT Dx23 - Product Status
  • EHT Dx23 - Product Description
  • T-COR 8 - Dengue Fever - Product Status
  • T-COR 8 - Dengue Fever - Product Description
  • T-COR 8 - Meningitis - Product Status
  • T-COR 8 - Meningitis - Product Description
  • Therapeutic Drug Monitoring Test - Resistant Cancer - Product Status
  • Therapeutic Drug Monitoring Test - Resistant Cancer - Product Description
  • VAC-3S Companion Diagnostic Test - Product Status
  • VAC-3S Companion Diagnostic Test - Product Description
  • Eurobio Scientific SA, Key Employees
  • Eurobio Scientific SA, Other Locations
  • Eurobio Scientific SA, Subsidiaries
  • Glossary
List of Figures
  • Eurobio Scientific SA Pipeline Products by Equipment Type
  • Eurobio Scientific SA Pipeline Products by Development Stage
  • Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Laboratoire HRA Pharma SAS
  • Ipsen SA
  • IntegraGen SA
  • Innate Pharma SA
  • ERYTECH Pharma SA
  • Biosynex SA
Note: Product cover images may vary from those shown
Adroll
adroll